EZR and endometrial cancer: Reduced expression of ezrin resulted in a decreased invasion capacity of breast cancer cells and a change in their morphology as spheroids on Matrigel [12], a significant reduction in proliferation, migration and invasion of lung adenocarcinoma cells [10], and a suppressed penetration of endometrial cancer cells through Matrigel membrane with no effect on proliferation rate [35].